
Sign up to save your podcasts
Or
In this episode, I analyze the impact of Nvidia's substantial investment of $50 million in Recursion, discussing its role in advancing AI-driven drug discovery and its implications for the pharmaceutical industry.
In this episode, I analyze the impact of Nvidia's substantial investment of $50 million in Recursion, discussing its role in advancing AI-driven drug discovery and its implications for the pharmaceutical industry.